Prognostic Value of Non-invasive Index of Endothelial Function.

• Register: ClinicalTrials.gov
• Last refreshed on: 13 December 2021
• Main ID: NCT03164226
• Date of registration: 14/05/2017
• Prospective Registration: No
• Primary sponsor: University of Monastir
• Public title: Prognostic Value of Non-invasive Index of Endothelial Function.
• Scientific title: Prognostic Value of Non-invasive Index of Endothelial Function in Emergency Department Patients With Undifferentiated Chest Pain
• Date of first enrolment: March 15, 2016
• Target sample size: 503
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03164226
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Tunisia

Contacts

• Name: nouira semir, MD
• Affiliation: University of Monastir

Key inclusion & exclusion criteria

Inclusion Criteria:

- Any patient = 25 years consulting for chest pain in the emergency department from 8:00
am to 8:00 pm (for the unavailability of the endopat device during the guard).

Exclusion Criteria:

- Chest pain of traumatic origin.

- Hemodynamic instability.

- Myocardial infarction requiring urgent revascularization.

- Parkinsonism: tremor problem.

- Refusal, communication problem.



Age minimum: 25 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Chest Pain

Major Adverse Cardiovascular Events

Intervention(s)

Device: Digital plethysmography in stratifying the cardiovascular risk for patients consulting for chest pain

Primary Outcome(s)

Prognostic performance of Endo-PAT in predincting major adverse cardiovascular events [Time Frame: 30 days]

Secondary ID(s)

ENDOPAT

Source(s) of Monetary Support

Please refer to primary and secondary sponsors